Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma

Double-hit lymphoma (DHL) is among the most aggressive and chemoresistant lymphoma subtypes. DHLs carry genomic abnormalities in MYC, BCL2, and/or BCL6 oncogenes. Due to the simultaneous overexpression of these driver oncogenes, DHLs are highly resistant to frontline therapies. Most DHLs overexpress...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuanhui, Azizian, Nancy G., Dou, Yaling, Pham, Lan V., Li, Yulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868798/
https://www.ncbi.nlm.nih.gov/pubmed/31752970
http://dx.doi.org/10.1186/s13045-019-0803-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868798/
https://www.ncbi.nlm.nih.gov/pubmed/31752970
http://dx.doi.org/10.1186/s13045-019-0803-9

Ejemplares similares